Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients

Adjuvant radiotherapy has no benefit following radical prostatectomy

Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC

Genomic testing: Awareness and effective communication between healthcare professionals and patients

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

McVie-Veronesi Awards:Harnessing machine learning to create predictive models in mitigating disease states

Writing IMRAD introduction, methods, results, discussion

Breast cancer staging and biological subtypes: clinical application

Early breast cancer

Cost-benefit analysis of new cancer medicines: The difficult choices of governments

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

OncoAlert Round Up for September 22-28, 2023